Related Experiment Video

Updated: Jun 21, 2026

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Angiogenesis in chronic hepatitis C is associated with inflammatory activity grade and fibrosis stage

Andrzej Gabriel1, Michał Kukla, Mariusz Wilk

  • 1Department of Pathomorphology in Zabrze, Medical University of Silesia, Zabrze, Poland. angabriel@wp.pl

Pathology, Research and Practice
|July 14, 2009
PubMed

Insights

In chronic hepatitis C (CHC), increased new blood vessel formation in liver tissue correlates with fibrosis and inflammation. This suggests inflammatory liver injury may drive angiogenesis in CHC.

Area of Science:

  • Hepatology
  • Vascular Biology
  • Immunology

Background:

  • Limited data exists on angiogenesis in chronic hepatitis C (CHC) liver tissue.
  • Understanding neo-angiogenesis in CHC is crucial for disease progression insights.

Purpose of the Study:

  • To investigate the association between histopathological features and new blood vessel counts in CHC.
  • To determine the localization and pattern of new vessel formation using CD 34 antigen expression.

Main Methods:

  • Analysis of liver biopsies from 74 CHC patients (genotype 1b) before antiviral therapy.
  • Quantification of new blood vessels in lobules and portal tracts.
  • Assessment of CD 34 antigen expression to map angiogenesis.

Main Results:

  • A positive association was found between the number of new blood vessels and fibrosis stage.
  • Increased inflammatory activity grade in liver biopsies correlated with higher vessel counts.
  • Neo-angiogenesis was prominent in portal tracts, fibrous septa, and periportal zones.

Conclusions:

  • Inflammatory hepatocyte injury appears to be a significant promoter of neo-angiogenesis in CHC.
  • Angiogenesis is linked to disease severity markers like fibrosis and inflammation in CHC.

More Related Videos

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice11:44

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice

Published on: March 24, 2015

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...